undamentalytics Newsletter

Surgery Partners, Inc. balance sheet

At the end of fiscal 2025, Surgery Partners, Inc. had total assets of $8.12bn and shareholders' equity of $1.71bn. It held $240m in cash against $3.74bn of debt: net debt of $3.50bn.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Surgery Partners, Inc.: balance sheet, annual
Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1375587018493318390283196270240217
Receivables—145178221308327382430456496579602617
Inventory—242629434656617175889799
Total current assets—2693113625885268029469218951,1191,1511,126
Goodwill3401,2991,4081,5553,3833,4023,4683,9124,1374,3265,0685,1955,204
Total assets—1,8592,1042,3054,6765,0195,4136,1186,6826,8777,8908,1208,050
Accounts payable—4345508397100125152172209209175
Total current liabilities—141181187349398557537493523624616579
Long-term debt—1,3391,2861,4752,3282,5962,8772,9582,6342,8043,4053,7353,648
Total debt01,3611,2861,4752,3282,5962,8772,9582,6342,8043,4053,7353,751
Shareholders' equity−14−264−4104052971161,0891,9981,9871,7901,7131,671
Net debt (negative = net cash)−131,2861,2281,4052,1442,5032,5592,5682,3512,6083,1353,4963,535
Shares outstanding———48m49m49m50m89m—127m127m129m131m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACHC vs SGRYBKD vs SGRYCON vs SGRYPACS vs SGRY

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Surgery Partners, Inc.